Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajit Kumar

Showing results (861-870 of 874) with videos related to

Pageof 88
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical TrialMelissa L Abel, Nobuyuki Takahashi, Cody Peer, et al.
European Journal of Pharmacology|May 31, 2022
Discovery and pre-clinical characterization of a selective PI3Kδ inhibitor, LL-00071210 in rheumatoid arthritisVijay Kanoje, Dilip Pandey, Akshaya Wagh, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Metastatic organotropism in small cell lung cancerManan Krishnamurthy, Anjali Dhall, Sarthak Sahoo, et al.
JAMA Oncology|October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical TrialNobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Cancer Discovery|April 22, 2026
BLOCKADE OF TUMOR-INTRINSIC TGF-Β SIGNALING DRIVES HYPERPROGRESSION IN SMALL CELL LUNG CANCERBrett A Schroeder, Chirayu Mohindroo, Anna-Lena Meinhardt, et al.
International Journal of Environmental Research and Public Health|January 21, 2023
Challenges in Accessing and Delivering Maternal and Child Health Services during the COVID-19 Pandemic: A Cross-Sectional Rapid Survey from Six States of IndiaSaurabh Sharma, Sumit Aggarwal, Ragini Kulkarni, et al.
International Journal of Disaster Risk Reduction : IJDRR|June 12, 2023
Gender differences in COVID-19 knowledge, risk perception, and public stigma among the general community: Findings from a nationwide cross-sectional study in IndiaA Stephen, Saritha Nair, Aparna Joshi, et al.
Frontiers in Public Health|October 31, 2022
Factors associated with COVID-19 stigma during the onset of the global pandemic in India: A cross-sectional studyTulsi Adhikari, Sumit Aggarwal, Saritha Nair, et al.
Journal of Medicinal Chemistry|December 10, 2020
Discovery of a Potent and Selective PI3Kδ Inhibitor (<i>S</i>)-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4<i>H</i>-quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer ModelsManojkumar R Shukla, Sukanya Patra, Mahip Verma, et al.
The Indian Journal of Medical Research|July 21, 2022
Development & validation of scales to assess stigma related to COVID-19 in IndiaSaritha Nair, Aparna Joshi, Sumit Aggarwal, et al.
Pageof 88

Showing results (861-870 of 874) with videos related to

Sort By:
Pageof 88
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical TrialMelissa L Abel, Nobuyuki Takahashi, Cody Peer, et al.
European Journal of Pharmacology|May 31, 2022
Discovery and pre-clinical characterization of a selective PI3Kδ inhibitor, LL-00071210 in rheumatoid arthritisVijay Kanoje, Dilip Pandey, Akshaya Wagh, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Metastatic organotropism in small cell lung cancerManan Krishnamurthy, Anjali Dhall, Sarthak Sahoo, et al.
JAMA Oncology|October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical TrialNobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Cancer Discovery|April 22, 2026
BLOCKADE OF TUMOR-INTRINSIC TGF-Β SIGNALING DRIVES HYPERPROGRESSION IN SMALL CELL LUNG CANCERBrett A Schroeder, Chirayu Mohindroo, Anna-Lena Meinhardt, et al.
International Journal of Environmental Research and Public Health|January 21, 2023
Challenges in Accessing and Delivering Maternal and Child Health Services during the COVID-19 Pandemic: A Cross-Sectional Rapid Survey from Six States of IndiaSaurabh Sharma, Sumit Aggarwal, Ragini Kulkarni, et al.
International Journal of Disaster Risk Reduction : IJDRR|June 12, 2023
Gender differences in COVID-19 knowledge, risk perception, and public stigma among the general community: Findings from a nationwide cross-sectional study in IndiaA Stephen, Saritha Nair, Aparna Joshi, et al.
Frontiers in Public Health|October 31, 2022
Factors associated with COVID-19 stigma during the onset of the global pandemic in India: A cross-sectional studyTulsi Adhikari, Sumit Aggarwal, Saritha Nair, et al.
Journal of Medicinal Chemistry|December 10, 2020
Discovery of a Potent and Selective PI3Kδ Inhibitor (<i>S</i>)-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4<i>H</i>-quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer ModelsManojkumar R Shukla, Sukanya Patra, Mahip Verma, et al.
The Indian Journal of Medical Research|July 21, 2022
Development & validation of scales to assess stigma related to COVID-19 in IndiaSaritha Nair, Aparna Joshi, Sumit Aggarwal, et al.
Pageof 88